Reprogramming Stars #3: Mechanisms of iPSC Reprogramming-An Interview with Dr. Keisuke Kaji.

Cell Reprogram

Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.

Published: October 2021

Download full-text PDF

Source
http://dx.doi.org/10.1089/cell.2021.29046.kkDOI Listing

Publication Analysis

Top Keywords

reprogramming stars
4
stars mechanisms
4
mechanisms ipsc
4
ipsc reprogramming-an
4
reprogramming-an interview
4
interview keisuke
4
keisuke kaji
4
reprogramming
1
mechanisms
1
ipsc
1

Similar Publications

Duchenne Muscular Dystrophy (DMD) is a genetic disorder characterized by disruptions in the dystrophin gene. This study aims to investigate potential a therapeutic approach using genetically modified human iPS-derived mesoangioblast-like cells (HIDEMs) in mouse model. This study utilizes patient-specific myoblasts reprogrammed to human induced pluripotent stem cells (iPSCs) and then differentiated into HIDEMs.

View Article and Find Full Text PDF
Article Synopsis
  • Diverse microbial pathogens block host protein synthesis, prompting the host to increase immune gene transcripts in a defensive response that may not always aid survival.
  • Research indicates that inhibiting translation initiation improves survival, while inhibiting translation elongation worsens it, revealing contrasting effects on host survival.
  • The study highlights the complex roles of translation initiation and elongation in immune responses and host survival during pathogen infections, suggesting distinct mechanisms at play.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!